EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma

Nicholas H Chakiryan iD, Youngchul Kim, Anders Berglund iD, Andrew Chang, Gregory J Kimmel, Ali Hajiran, Jonathan Nguyen, Carlos Moran-Segura iD, Daryoush Saeed-Vafa, Esther N Katende, Neale Lopez-Blanco, Jad Chahoud iD und 12 weitere

Journal for ImmunoTherapy of Cancer · 2023-04 · 11 (4) · e006195

DOI: 10.1136/jitc-2022-006195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 25.04.2023. Verfasst von Nicholas H Chakiryan und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Department of Defense United States Army Medical Research Acquisition Activity, Moffitt Cancer Center Genitourinary Oncology Fellowship Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In clear cell renal cell carcinoma (ccRCC), tumor-associated macrophage (TAM) induction of CD8+T cells into a terminally exhausted state has been implicated as a major mechanism of immunotherapy resistance, but a deeper biological understanding is necessary.

Methods

Primary ccRCC tumor samples were obtained from 97 patients between 2004 and 2018. Multiplex immunofluorescence using lymphoid and myeloid markers was performed in seven regions of interest per patient across three predefined zones, and geospatial analysis was performed using Ripley’s K analysis, a methodology adapted from ecology.

Results

Clustering of CD163+M2 like TAMs into the stromal compartment at the tumor–stroma interface was associated with worse clinical stage (tumor/CD163+nK(75): stage I/II: 4.4 (IQR −0.5 to 5.1); stage III: 1.4 (IQR −0.3 to 3.5); stage IV: 0.6 (IQR −2.1 to 2.1); p=0.04 between stage I/II and stage IV), and worse overall survival (OS) and cancer-specific survival (CSS) (tumor/CD163+nK(75): median OS–hi=149 months, lo=86 months, false-discovery rate (FDR)-adj. Cox p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPrognosisCD8-Positive T-LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

CD8-Positive T-LymphocytesKidney NeoplasmsMacrophagesTumor Microenvironment

Autor:innen und Institutionen

  • Department of Genitourinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Translational Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, Oregon, USA.
  • Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Integrated Mathematical Oncology Department, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Department of Pathology, H Lee Moffitt Cancer Center, Tampa, Florida, USA.
  • Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Nicholas H Chakiryan, Anders Berglund, Carlos Moran-Segura, Jad Chahoud, Phillip Rappold, Philippe E Spiess, Liang Wang, Jamie K Teer, Fengshen Kuo, Abraham Ari Hakimi, Philipp M Altrock, James J Mulé, Brandon J Manley

Förderung

  • NCI NIH HHS
  • Department of Defense United States Army Medical Research Acquisition Activity
  • Moffitt Cancer Center Genitourinary Oncology Fellowship Research

Zitieren

APA

Chakiryan, N. H., Kim, Y., Berglund, A., Chang, A., Kimmel, G. J., Hajiran, A., Nguyen, J., Moran-Segura, C., Saeed-Vafa, D., Katende, E. N., Lopez-Blanco, N., Chahoud, J., Rappold, P., Spiess, P. E., Fournier, M., Jeong, D., Wang, L., Teer, J. K., Dhillon, J., …, & Manley, B. J. (2023). Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer, 11(4), e006195. https://doi.org/10.1136/jitc-2022-006195

Vancouver

Chakiryan NH, Kim Y, Berglund A, Chang A, Kimmel GJ, Hajiran A, et al. Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 2023;11(4):e006195. doi:10.1136/jitc-2022-006195

BibTeX
@article{Chakiryan2023,
  author = {Chakiryan, Nicholas H and Kim, Youngchul and Berglund, Anders and Chang, Andrew and Kimmel, Gregory J and Hajiran, Ali and Nguyen, Jonathan and Moran-Segura, Carlos and Saeed-Vafa, Daryoush and Katende, Esther N and Lopez-Blanco, Neale and Chahoud, Jad and Rappold, Phillip and Spiess, Philippe E and Fournier, Michelle and Jeong, Daniel and Wang, Liang and Teer, Jamie K and Dhillon, Jasreman and Kuo, Fengshen and Hakimi, Abraham Ari and Altrock, Philipp M and Mulé, James J and Manley, Brandon J},
  title = {Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  volume = {11},
  number = {4},
  pages = {e006195},
  doi = {10.1136/jitc-2022-006195}
}
Kostenlos starten →